Quest Diagnostics Inc (NYSE:DGX)
During the Trading Day
| 61.89 |  -0.50 / -0.80% |
Data as of 4:04pm ET | Day’s Change |
During After-Hours Switch to standard view »
| 61.89 |  0.00 / 0.00% |
Volume: 1.7K |
Latest DGX News | Press Releases
| Why This Health Care Play Looks Like a Good Value Jun 14 / MotleyFool.com | 4 Stocks Raising The Health Services Industry Higher Jun 13 / TheStreet.com |
| Myriad Ruling Causes 15 Percent Swing Thursday b Here's Why Jun 14 / Benzinga | Quest Scans 2Q; Maintains FY13 View - Analyst Blog Jun 10 / Zacks.com |
| Wall Street Realizes Myriad Genetics Monopoly on Breast Cancer Risk Tests Is Done Jun 14 / TheStreet.com | Quest and Hologic Extend Ties - Analyst Blog Jun 07 / Zacks.com |
Today’s Trading
| Previous close | 62.39 |
| Today’s open | 62.46 |
| Day’s range | 61.86 - 62.67 |
| Volume | 787,590 |
| Average volume (3 months) | 1,292,704 |
| Market cap | $9.9B |
| Dividend yield | 1.94% |
Data as of 4:04pm ET, 06/19/2013
Growth & Valuation
| Earnings growth (last year) | +18.49% |
| Earnings growth (this year) | -0.18% |
| Earnings growth (next 5 years) | +12.00% |
| Revenue growth (last year) | -1.70% |
| P/E ratio | 17.0 |
| Price/Sales | 1.25 |
| Price/Book | 2.37 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| LHLaboratory Corporati... | -0.77 | -0.76% |
| EXAMExamWorks Group Inc | -0.13 | -0.63% |
| GNMKGenmark Diagnostics ... | +0.22 | +2.30% |
| NEONeogenomics Inc | -0.09 | -2.21% |
Data as of 4:04pm ET, 06/19/2013
Financials
| Next reporting date | July 23, 2013 |
| EPS forecast (this quarter) | $1.10 |
| Annual revenue (last year) | $7.4B |
| Annual profit (last year) | $553.2M |
| Net profit margin | 8.50% |
Profile
Sector Health Services |
Industry Services to the Health Industry |
President, Chief Executive Officer & Director Stephen H. Rusckowski |
Senior Vice President- Operations John B. Haydon, MBA |
Corporate headquarters Madison, New Jersey |
Forecasts
